Quantcast

Latest Chikungunya Stories

2012-03-14 20:51:59

1.         Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR´s Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease. Working in close collaborations with Singapore clinician-scientists and international researchers, Dr Lisa Ng, Principal Investigator of the Chikungunya research group at SIgN, led the team to discover a direct biomarker which serves as an early and...

2011-08-12 12:35:06

NIH awards $3 million to prepare for clinical trials; developers hope vaccine will alleviate suffering caused by mosquito-borne virus in Asia and Africa and limit its spread Researchers have developed a new candidate vaccine to protect against chikungunya virus, a mosquito-borne pathogen that produces an intensely painful and often chronic arthritic disease that has stricken millions of people in India, Southeast Asia and Africa. A single dose of the experimental vaccine protected lab mice...

2011-07-22 14:34:21

An experimental research carried out in Sant Cugat del Valls and Rubí, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos (Aedes albopictus). The research began in February 2008. The research focused on monitoring eggs found in small experimental traps. Researchers observed that for the first time, the number of eggs diminished after applying the measures. The strategies began with a visit to...

2011-06-18 01:45:14

Guest edited by Brandeis professor Donald Shepard, it contains 7 original studies co-authored by Brandeis researchers The ten studies in this special issue document the substantial and growing burden of dengue in the Americas, Africa and Asia, and the burden of a chikungunya outbreak in India. Luiz Tadeu Moraes Figuedo's paper on dengue in Brazil confirms the country's worsening trend; from 1999-2009, where cases rose at 6.2% per year and dengue deaths at 12.0% per year. Carmen Perez and...

2011-06-14 19:00:00

JAKARTA, Indonesia, June 14, 2011 /PRNewswire/ -- The Association of Southeast Asian Nations (ASEAN) launched the first ASEAN Dengue Day today in Indonesia, with related events occurring throughout the ASEAN member states. The date was chosen to coincide with the month in which dengue infections in the region typically peak. ASEAN Dengue Day is a new enterprise in the fight against dengue, aiming to: Increase public awareness of dengue to help to reduce the risk of dengue transmission...

2011-05-06 00:25:40

Researchers probing genetics of chikungunya virus identify tiny changes separating epidemic African strain and tamer Asian variety What causes a virus to suddenly begin infecting large numbers of people? Scientists have long known that the process they call "viral emergence" involves a wide variety of factors. Some are changes in the environment, either generated by natural causes or human activity. Others are internal, arising from accidental changes "” mutations "”in the virus'...

2011-05-05 11:52:00

MENLO PARK, Calif., May 5, 2011 /PRNewswire/ -- In parts of the world where dengue fever is common, other viral infections are often misdiagnosed. Such misdiagnosis is a waste not only of time and money. It can be especially problematic for sufferers of another mosquito-borne viral infection called chikungunya--its high fever, joint pain that can last for years, and intense headache symptoms mimic the clinical profile of dengue. Recovery from the acute phase of the infection can take from...

2011-02-16 14:55:07

 The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS (NYSE Euronext: VLS), a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment. The international team of scientists, coordinated by Dr Lucile Warter of SIgN, has published their groundbreaking discovery in...

2010-07-15 05:00:00

ROCKVILLE, Md., July 15 /PRNewswire/ -- MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million. These grants will help MacroGenics further advance its Dual-Affinity Re-Targeting (DART), or bispecific antibody scaffold platform, as well as its...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related